Twist Bioscience's Chief Legal: What Investors Need to Know
A senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
This piece highlights safer starter options, basic risk controls, and practical tips to protect your early crypto portfolio.
19,284 articlesA senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
A growing online debate over Roth vs Traditional 401(K) strategies is getting a reality check. Experts say the decisi...
A Perdoceo director recently exercised 9,308 options and sold shares, triggering questions for investors. This guide ...
When a robinhood insider just bought a large block of stock, investors take notice. This article digs into what insid...
A quiet international fund is flashing some of the strongest gains in 2026. Schwab’s international ETF has climbed sh...
Oracle stock dips despite a swelling backlog. This guide explains what backlog means, why the stock reacts, and how i...
Imagine a blockbuster SpaceX IPO that raises $75 billion and pays banks a record underwriting fee. This article break...
Target just raised dividend by a modest 1.8%, marking 55 straight years of increase. This article explains why the mo...
Investors are buzzing about SpaceX's ambitious revenue target for 2030 and a bold rival coming from AI. This guide br...
When markets wobble, savvy investors turn to reliable income. Here are three excellent dividend stocks to buy on the ...
Two graduates, identical diplomas, different backgrounds. The paycheck ten years later can still tell a different sto...
A broad crypto rebound is lifting Coinbase as the company pivots toward subscriptions and services. Analysts see upsi...